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PharmacokineticsAbstract Reduction or elimination of traditional hazardous chemicals in chromatographic separa-
tion and sample preparation is comparatively safer and can be considered as a greener approach for
the determination of analytes in biological matrices. A rapid and sensitive UHPLC-MS/MS assay
for determination of quetiapine in rat plasma was developed and validated using environment
friendly and low toxic organic solvents as organic modiﬁer in mobile phase and sample preparation.
Quetiapine and risperidone (internal standard) were separated on Acquity BEH C18 column
(50 · 2.1 mm, i.d. 1.7 lm) using ethanol–water-formic acid (80:20:0.1, v/v/v) as mobile phase at a
ﬂow rate of 0.3 mL/min. Detection was performed on tandem mass spectrometer using positive elec-
trospray ionization source by multiple reaction monitoring mode. The precursor to product ion
transitions of m/z 384.13 > 253.00 for quetiapine and m/z 411.18 > 191.07 for IS was used to
quantify them respectively. The method was found to be linear in the concentration range of
0.45–500 ng/mL. All validation parameters were within acceptable range, as deﬁned by guidelines
of bio-analytical method validation. In conclusion, bioanalytical assay using UHPLC-MS/MS
together with environment friendly and low toxic organic solvents in mobile phase and sample prep-
aration may be considered as greener approach for quantiﬁcation of analytes in plasma samples.
ª 2014 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Solvents, commonly used in analytical methodologies, are
mostly volatile organic compounds that are hazardous to our
environments. They lead to air pollution, are ﬂammable in nat-
ure and can cause toxicity and/or carcinogenicity (Salvador
Garrigues and de la Guardia, 2010). Green analytical chemis-
try is a modern era technique that involves methods to reduceetiapine
2 M. Iqbalor eliminate the use of the hazardous solvents, reagents, preser-
vative and other chemicals that are harmful to human health
or environment without compromising the performance and
quality of analysis (Keith et al., 2007; Namies´nik, 2001). In
the recent years, rapid rise in development of green analytical
methods has been observed that has results to extensive
research and high rate of publications in this area
(Agnieszka Gauszka and Namies´nik, 2013; Christopher J.
Welch et al., 2010; Haq et al., in press; Armenta et al., 2008;
Tache et al., 2013; Tobiszewski et al., 2010; Vaher and
Kaljurand, 2012).
Recently, few attempts have also been explored in literature
for the use of environment friendly approach in bioanalytical
technique (Bojko and Pawliszyn, 2012; Fountain, 2012;
Ghosh, 2012; Heudi, 2012; Kaljurand and Koel, 2012;
Rainville et al., 2012; Tsai et al., 2012). Green approach in
bioanalytical methods can be implemented during chromato-
graphic separation and sample preparation. Conventional
HPLC mobile phase techniques (which use acetonitrile and/
or methanol) are replaced with environment friendly alterna-
tives such as water, ethanol, isopropanol or propyl carbonate
(Rainville et al., 2012; Smith, 2008; Tache et al., 2013).
Similarly, use of carbon dioxide in supercritical ﬂuid chroma-
tography (Dispas et al., 2012), reduction in consumption of
solvents or additives through reduced column internal diame-
ters (narrow or microbore ranges) and dimensions of packing
(62 lm) (Sandra et al., 2010; Zotou, 2012) adapted as the envi-
ronment friendly approach in chromatographic separation.
Additionally, selection of less harmful organic substitutes
(e.g. ethyl acetate, 2-butanol) in liquid–liquid extraction
(LLE), practices of liquid and solid phase micro-extraction
(Abdel-Rehim and Abdel-Rehim, 2013; Farhadi et al., 2012;
Kataoka, 2011; Kataoka and Saito, 2011) and sample reduc-
tion using dried blood sampling (Heudi, 2012) are becoming
more popular methods and favorable choice in sample
preparation.
Among the available analytical techniques; ultra-high per-
formance liquid chromatography (UHPLC) has gained a con-
siderable attention as both chromatographic separation and
assay selectivity have been signiﬁcantly improved using this
technology (Liu et al., 2009). Use of Aquity BEH column in
UHPLC, which not only increase the separation throughput
and efﬁciency but also reduces the retention time and volume
of solvent required during separation (Kumar et al., 2012; Li
et al., 2008; Novakova et al., 2006). Considering all these
above mentioned advantages, UHPLC may be useful for
greener approaches in bioanalytical assay (Cielecka-Piontek
et al., 2013).
Quetiapine (QUE), a dibenzothiazepine derivative is an
atypical antipsychotic, indicated for the treatment of schizo-
phrenia, acute mania in bipolar disorders, and bipolar
depression in adults. It has also been found to be effective as
a monotherapy and as an adjunctive to a mood stabilizer
(Altamura et al., 2011; Chiesa et al., 2012; Dispas et al.,
2012; Patteet et al., 2012; Vieta et al., 2010). Therapeutic drug
monitoring is a common and an important requirement in
antipsychotic treatment to control the compliance and avoid-
ance of extrapyramidal side effects (Hiemke et al., 2004;
Musenga et al., 2009). It is important to perform accurate
monitoring of QUE levels in blood in order to reduce the side
effects and to optimize treatment. In view of this, to date,
innumerable assays have been reported for quantiﬁcation ofPlease cite this article in press as: Iqbal, M. UHPLC-MS/MS assay using environment
in rat plasma. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabQUE (alone and in combination with other drugs) in biologi-
cal matrices (e.g. plasma, serum, tissue, oral ﬂuids and micro-
somes). These techniques include HPLC with UV detection
(Davis et al., 1999; Frahnert et al., 2003; Hasselstrom and
Linnet, 2003; Mandrioli et al., 2002; Mercolini et al., 2007;
Sachse et al., 2006; Saracino et al., 2006) gas chromatography
mass spectroscopy (GC MS) (da Fonseca et al., 2013;
Langman et al., 2004; Pullen et al., 1992) liquid chromatogra-
phy mass spectroscopy (Zhou et al., 2004), liquid chromatog-
raphy tandem mass spectroscopy (LC-MS/MS) (Barrett
et al., 2007; Davis et al., 2010; Fisher et al., 2012a,b;
Kirchherr and Kuhn-Velten, 2006; Li et al., 2004; Lin et al.,
2004; Nirogi et al., 2008; Ostad Haji et al., 2013; Pan et al.,
2012; Xiong et al., 2013) and UHPLC-MS/MS (Amundsen
et al., 2013; Ansermot et al., 2013; Ji-Ying Tu et al., 2008; Li
et al., 2007; Patteet et al., 2013). Most of the above mentioned
techniques are low sensitive as well as time consuming.
Although, the previously reported LC-MS/MS and UHPLC-
MS/MS methods were also sensitive, but the solvents used in
chromatographic separation and sample preparation falls
under the category of hazardous wastes which causes serious
environment, health, and safety (EHS) concerns, including
human and eco-toxicity issues (Cielecka-Piontek et al., 2013;
Rainville et al., 2012; Salvador Garrigues and de la Guardia,
2010).
Despite of available possibilities for green bioanalytical
approach, very meager information exists regarding its use.
To the best of our knowledge, only one validated method is
available in literature, which used the greener approach for
bioanalysis throughout the study (Cheregi et al., 2013).
Therefore, the present study aimed to develop a generic
UHPLC-MS/MS method using environment friendly and
low toxic solvents, a green approach, which can facilitate the
rapid determination of QUE in plasma samples.
2. Experimental
2.1. Chemicals and reagents
Quetiapine (purityP 98 %) and risperidone (internal stan-
dard; purityP 98%) were used as reference substance in this
study. QUE was received as a gratis from Ranbaxy Laborato-
ries India and risperidone was purchased from Sigma–Aldrich
(St. Louis, MO), USA. Ethanol, ethyl acetate and methanol
were of HPLC grade and were obtained from VWR Interna-
tional Ltd. UK. Formic acid and sodium hydroxide were of
analytical grade and obtained from Qualikems Fine Chem.
Pvt. Ltd., Vadodara India. All aqueous solutions used in this
study were prepared by using Milli-Q water puriﬁed method
using Milli-QR Gradient A10R (Millipore, Moscheim Cedex,
France) with pore size 0.22 lm. Blank plasma was prepared
in laboratory from drug free healthy rats which were obtained
from the Animal Care and Use Centre, College of Pharmacy,
King Saud University, Riyadh, Saudi Arabia and was stored at
80 C until used.
2.2. Calibration standards and quality control samples
Standard stock solutions (100 lg/mL) of QUE and risperidone
(IS) were prepared in methanol and kept in the refrigerator at
4 C for use within 15 days of preparation. Working solutionsfriendly organic solvents: A green approach for fast determination of quetiapine
jc.2014.11.039
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solution using methanol:water (50:50, v/v). A 20 lL aliquot
of each working solutions was added to 200 lL of blank rat
plasma to obtain the ﬁnal calibration standard between 0.45
and 500 ng/mL. Quality control (QC) samples at four different
concentrations: 0.48, 1.5, 60 and 400 ng/mL in blank rat plasma
were also prepared in a similar manner and treated as lower
limit of quantiﬁcation for QC (LLOQ QC), low QC (LQC),
mid QC (MQC) and high QC (HQC) respectively. Spiked
plasma calibration standards and quality control samples were
kept at 80 C until used during validation and/or analysis.
The IS working solution (200 ng/mL) for routine use was pre-
pared by diluting the risperidone stock solution in metha-
nol:water (50:50, v/v) and was kept in the refrigerator at 4 C.
2.3. UHPLC separation and MS/MS parameters
The equipment consisted of ACQUITY UHPLC system
coupled to triple–quadruple tandem mass spectrometer Micro-
mass Quattro micro (Waters Corp., Milford, MA, USA).
The UHPLC system included quaternary solvent manager, a
binary pump, degasser, autosampler with an injection loop
of 10 lL and a column heater–cooler. The chromatographic
separation was performed on Acquity BEH C18 column
(50 · 2.1 mm, i.d., 1.7 lm, Waters, USA) maintained at tem-
perature of 40 ± 2 C. The mobile phase composed of etha-
nol–water-formic acid (80:20:0.1, v/v/v) at a ﬂow rate of
0.3 mL/min. The injection volume was 10 lL in partial loop
mode and the temperature of the autosampler was 15 ± 2 C.
Triple–quadruple tandem mass spectrometer equipped with
electrospray ionization (ESI) interface was used for analytical
detection. The detection was performed in ESI positive mode
using multiple reaction monitoring (MRM) by the ion
transitions of m/z 384.13 > 253.00 for QUE and m/z
411.18 > 191.07 for IS, having dwell time of 0.161 s. Nitrogen
was used as a desolvating gas at a ﬂow rate of 650 L/h. The
desolvating temperature was 350 C whereas source tempera-
ture was 150 C. The collision gas (argon) ﬂow was 0.1 mL/
min and capillary voltage was set at 3.5 kV. The compound
parameters such as cone voltage and collision energy were
set at 40 V and 24 eV for QUE and 42 V and 30 eV for IS
respectively. The Mass Lynx software (Version 4.1, SCN
714) was used to control the UHPLC-MS/MS system. Data
were collected and processed using TargetLynx program.
2.4. Sample preparation
Plasma samples stored at 80 C were thawed at room tem-
perature and vortexed for 30 s before sample preparation. In
a clean 10 mL-glass tube, an aliquot of 200 lL of spiked cali-
bration standards, QCs and unknown plasma samples were
transferred and 10 lL of IS (200 ng/mL) was added in each
tube except blank. The 50 lL of 0.1 M sodium hydroxide
was added into each tube and vortexed for 30 s. Then, 2 mL
of ethyl acetate was added into each tube and again vortexed
gently for 3 min followed by centrifugation for 5 min at
4000g and 4 C. After centrifugation, upper portion of the
organic layer was transferred to a clean test tube, and evapo-
rated to dryness under a stream of nitrogen at approximately
40 C. The dried extracts were reconstituted in 200 lL of
ethanol and transferred into HPLC vials for the analysis.Please cite this article in press as: Iqbal, M. UHPLC-MS/MS assay using environment
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The developed assay was fully validated in rat plasma accord-
ing to guidelines of bioanalytical method validation set by the
United States Food and Drug Administration and European
Medicines Agency (EMA, 2011; FDA, 2001). The evaluated
validation parameters included selectivity, linearity of
response, accuracy, precision, matrix effects, recovery, dilution
integrity and stability of analytes in both short-term sample
processing and long-term storage.
Method selectivity was assessed by comparing the chromato-
grams of blank rat plasma samples with chromatograms of
spiked plasma samples at LLOQ (0.45 ng/mL) and IS (20 ng/
ml). The response of interferences in blank plasma was limited
to620%of the response of analytes and65%of the IS. The lin-
earity of the method was determined by plotting the plasma cal-
ibration curve in triplicate at eight different concentrations
ranging from 0.45 to 500 ng/mL. The precision of the assay
was expressed as percentage coefﬁcient of variation (% CV) at
four different concentrations whereas accuracy was expressed
as a percentage of deviation from the respective nominal value.
The intra-day and inter-day precision and accuracy were evalu-
ated at four differentQCconcentration levels (LLOQQC,LQC,
MQC and HQC) in six replicate on the same day and on three
different days, respectively. The recoveries of QUE at three
QC levels were determined by comparing peak area ratios of
plasma spiked with analyte prior to extraction with the peak
area ratios of plasma spiked with analyte after the extraction.
The matrix effects were determined by calculating the peak area
ratio of extracted rat plasma postspiked with analyte to the peak
area of the analyte in mobile phase in the same concentration.
Deviation in analyte concentrations of a maximum of 15%
was considered acceptable and in line with current EMEA
guideline (EMA, 2011). The extraction recovery and matrix
effects of IS were also evaluated using the same procedure.
The stability of QUE in rat plasma under different antici-
pated conditions was assessed by using six replicates of LQC
and HQC. Bench-top stability was assessed after keeping the
plasma samples to room temperature for 6 h, the freeze–thaw
stability was determined after three cycles of freeze–thaw. Auto-
sampler storage stability was determined by storing the recon-
stituted QC samples for 48 h under autosampler condition
(maintained at 15 C) before analysis. Long-term stability was
assessed after storage of the test samples at around 80 C
for 60 days. The working solutions and stock solutions of
QUE and the IS were also evaluated for their stability at room
temperature for 12 h and at refrigerator temperature (below
10 C) for 15 days. Dilution integrity exercise was carried out
to ensure the integrity of analyte in those samples which were
beyond upper limit of the standard curve and need to be diluted.
A fresh stock of QUE was prepared and spiked in plasma to get
a concentration level of 1.8 times of highest standard of the
usual calibration standard, and then diluted 2 and 4 times with
the same plasma. Six aliquots of both dilutions were processed
along with freshly spiked calibration standards and analyzed by
back calculation using regression equation obtained.
2.6. Application to pharmacokinetic interaction study in rats
To demonstrate the utility of this assay, method was applied to
pharmacokinetic interaction study of QUE with green teafriendly organic solvents: A green approach for fast determination of quetiapine
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4 M. Iqbalextracts (GTE) in rats. Twelve male wistar albino rats weigh-
ing from 180 to 220 g were randomly divided into two groups
(6 in each). Experiments were carried out according to the
guidelines of the animal care and use committee at King Saud
University. Rats in treatment group received GTE (175 mg/kg,
oral) for seven days, while control group received normal sal-
ine in same volume. Blood samples (approximately 0.5 mL)
were collected from the retro-orbital plexus into heparinized
microfuge tubes at 0, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 8 and 12 h after
administration of QUE (25 mg/kg, oral; suspended in 1%
hydroxyl propyl methyl cellulose) in both groups. Plasma sam-
ples were harvested by centrifuging the blood at 5000g for
10 min and stored at 80 ± 10 C until analysis.
3. Results
3.1. Method development
UHPLC-MS/MS operation parameters were carefully
optimized before detection by tandem mass spectrometry
using MRM of precursor–product ion transitions at m/z
384.13 > 253.0 for QUE and m/z 411.18 > 191.07 for IS.
Initially the standard solution (200 ng/mL) of both QUE andFigure 1 Precursor and product ion spectra for quetia
Please cite this article in press as: Iqbal, M. UHPLC-MS/MS assay using environment
in rat plasma. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabIS was directly infused into the mass spectrometer for tuning
in both positive and negative modes using ESI as the ioniza-
tion source. It was observed that the signal intensity of positive
ion (ESI+) was much higher than that of negative ion for both
analyte and IS. Parameters, such as capillary and cone voltage,
desolvation temperature, ESI source temperature and ﬂow rate
of desolvation gas and cone gas were optimized to obtain the
optimum intensity of protonated molecular ions (M–H)+ of
QUE and IS. Analyte produced the strongest product ion
and daughter ion signals when cone voltage and collision
energy were set at 40 V and 24 eV respectively. For IS, the
optimized cone voltage and collision energy were 42 V and
30 eV respectively. The precursor and product ion spectra of
QUE and IS are shown in Fig. 1.
Feasibility of different compositions of ethanol and iso-
propranol and water containing 0.1% formic acid as mobile
phase were tried for separation of analyte and IS with altered
ﬂow-rates (in the range of 0.2–0.4 mL/min) on BEH C18 col-
umn (50 · 2.1 mm, i.d. 1.7 lm). The best peak resolution along
with high sensitivity was achieved with an isocratic elution by a
mobile phase comprising of ethanol–water-formic acid
(80:20:0.1, v/v/v) at a ﬂow-rate of 0.3 mL/min. The column
oven temperature also optimized at 40 C to adjust the backpine (A1 and A2) and IS (B1 and B2), respectively.
friendly organic solvents: A green approach for fast determination of quetiapine
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UHPLC-MS/MS assay for quetiapine determination 5pressure which was ﬁnally set to approx. 8000 psi. The selected
conditions were found to be suitable for the separation and
determination of electrospray response for QUE and IS.
Clean samples are essential to minimize ion suppression
and matrix effect in bioanalysis. Initially protein precipitation
using ethanol and/or isopropranol was evaluated for sample
preparation but the results were not satisfactory in terms of
recovery and matrix effects. Finally, liquid-liquid extraction
(LLE) using ethyl acetate, tertiary butyl ethyl ether and
2-butanol was tried as extracting solvents. Ethyl acetate pro-
duced better results compared to others. Extraction rate was
also increased by alkalization of the compounds by adding
50 lL of 0.1 M sodium hydroxide before ethyl acetate. Effects
of different extracting solvents (ethyl acetate, tertiary butyl
ethyl ether and 2-butanol) on quetiapine recovery and matrix
effects are shown in Fig. 2.
3.2. Method validation
3.2.1. Selectivity
No signiﬁcant peaks in blank plasma samples were detected at
the corresponding retention time of analyte and IS. Represen-
tative MRM chromatograms of analyte and IS for blank
plasma (showing no signiﬁcant interference at the retention
time of analyte and IS) as well as plasma spiked at LLOQ level
are shown in Fig. 3A and B, respectively.
3.2.2. Linearity and lower limit of quantiﬁcation
The linearity of the method was determined by a weighted
(1/X2) least square regression analysis of standard plot associ-
ated with eight-point standard curve. The calibration curves
were generated by plotting area ratio (analyte/IS) as a function
of QUE concentration. The method was found to be linear in
range between 0.45 and 500 ng/mL for QUE in rat plasma and
LLOQ for this assay was 0.45 ng/mL. The determination
coefﬁcients (r2) were found to be consistently P0.997 during
the course of validation.0
20
40
60
80
100
Ethyl acetate 2-Butanol Terary butyl ethyl 
ether
(%) Recovery
Marx eﬀects
Figure 2 Extraction recovery and matrix effects
(%Mean ±%CV) of different extracting solvents at MQC
concentration of quetiapine in rat plasma (n= 3).
Please cite this article in press as: Iqbal, M. UHPLC-MS/MS assay using environment
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The precision and accuracy data for QC samples (both inter-
day and intra-day) are listed in Table 1. The intra-day and
inter-day precision results were 3.8–11.3% and 4.5–9.1%,
respectively; whereas the intra-day and inter-day accuracies
were 91.1–112% and 94.5–112%, respectively. The accuracy
was required to be limited to within ±15% (20% for LOQ
QC) and precision was not to exceed ±15% (20% for LOQ
QC.)
3.2.4. Recovery and matrix effects
The percentage recoveries (mean ± SD) of QUE obtained
from plasma at three different QC concentrations level (1.50,
60 and 400 ng/mL) were 76.9%, 73.9% and 71.4% respec-
tively. Mean recovery for the risperidone (IS) at the concentra-
tion employed was 67.3% (Table 2). These results indicate that
the extraction efﬁciency for QUE using LLE method was sat-
isfactory, consistent and concentration independent. The ion
suppression effects were within 615% and its relative standard
deviation (%CV) was within ±5% among all QC concentra-
tion, indicated no relative matrix effects (Table 2).
3.2.5. Stability and dilution integrity
The stability and dilution integrity results are summarized in
Table 3. These indicate that QUE spiked in rat plasma was sta-
ble for at least 6.0 h at room temperature, 48 h in autosampler,
60 days at around 80 C and during three cycle of freeze–
thaw when stored at around 80 C. The stock solutions
and working standard of QUE and IS were also stable for
15 days at refrigerator temperature (below 10 C) and for
12 h at room temperature. In dilution integrity study, the per-
centage accuracy of two and four times diluted samples was to
96.3% and 97.0% of the nominal concentration for QUE.
These results indicated that the dilution of the concentrated
plasma sample up to four times maintains legibility and integ-
rity of QUE concentration.
3.3. Pharmacokinetic interaction study in rats
The applicability of this validated method was demonstrated
successfully in a pharmacokinetic interaction study of QUE
with GTE. Representative MRM chromatogram of analyte
and IS after one hour administration of QUE alone in rat
are shown in Fig. 3C. The mean plasma concentration verses
time proﬁle of QUE is shown in Fig. 4.
4. Discussion
Binary mixture of water and polar organic solvents like meth-
anol and acetonitrile comprise the majority of mobile phase
utilized for liquid chromatography. These agents are used
due to their miscibility with water, low viscosity, ability to pro-
duce good chromatographic peak shape and compatibility
with UV and MS detection. Unfortunately, these solvents pro-
duce substantial hazards to the analysts during handling as
well as produce harmful effects on the environment. In this
study, the primary focus on the selection of the mobile phase
was the replacement of these traditional (methanol and aceto-
nitrile) solvents with non-traditional, less hazardous, environ-
ment friendly benign organic solvents. Non-traditional,friendly organic solvents: A green approach for fast determination of quetiapine
jc.2014.11.039
Figure 3 Representative MRM chromatograms of quetiapine and IS in (A) blank plasma; (B) plasma spiked at LLOQ level and (C) at
one hour after oral administration of QUE 25 mg/kg in rat.
6 M. Iqbalalcoholic mobile phase; like, ethanol and isopropranol
revealed promising results in replacing the traditional use of
acetonitrile and methanol (Rainville et al., 2012). However,
high viscosity of these two non-traditional solvents was the
main challenge which could result in high back pressure during
the process of separation. UHPLC chromatographic system is
designed in a special way to withstand high system back-pres-
sures, and the separation on it can be easily performed under
very high pressures (up to 1000 psi), without any negative
impact on analytical column or other components of chro-
matographic system (Novakova et al., 2006). In this study,
the use of ethanol with the adjusted back pressure (approx.
8000 psi) and the column oven temperature (40 C) was found
to be suitable for the separation and determination of electro-
spray response for QUE and IS. Finally, mixture of ethanol–
water-formic acid (80:20:0.1) was selected for chromatographic
separation of quetiapine. Chromatographic separation of pre-
viously reported green bio-analytical assay (Cheregi et al.,
2013) was based on mixture of propylene carbonate/ethanol
in 7:3 ratio.Please cite this article in press as: Iqbal, M. UHPLC-MS/MS assay using environment
in rat plasma. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabCommonly used sample preparation technique such as pro-
tein precipitation, LLE and solid phase extraction (SPE) gener-
ally consume substantial amount of organic solvents.
Phospholipids present in plasma are considered as one of the
most signiﬁcant matrixes interferences encounter in protein
preparation methodologies (Phillips and Dodge, 1967). But,
due to ease and compatibility with mobile phase, sample extrac-
tion by protein precipitation using acetonitrile and/or methanol
is often preferred over other solvents. However, both of them
have been reported to less effective in the removal of the phos-
pholipids compared to ethanol and isopropranol (Rainville
et al., 2012). During this study, protein precipitation using eth-
anol and/or isopropranol in the presence or absence of acetic
acid/formic acid was evaluated for sample preparation but the
efforts resulted poor recoveries and sensitivity. LLE is one of
the preferred sample preparation techniques during assay devel-
opment that provides cleaner extracts than protein precipitation
processes in most cases. LLE is more cost effective than SPE,
especially when only non-halogenate extraction solvents such
as hexanes and ethyl acetate are used. Tertiary butyl methylfriendly organic solvents: A green approach for fast determination of quetiapine
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Table 1 Intra-day and inter-day precision and accuracy of QUE in rat plasma.
Nominal concentration (ng/mL) Run Mean ± SD (ng/mL) Precision (CV%) Accuracy (%)
Intra-day variation (six replicate at each concentration)
0.48 1 0.54 ± 0.03 5.5 112
2 0.53 ± 0.06 11.3 110
3 0.53 ± 0.05 9.4 111
1.50 1 1.56 ± 0.11 7.0 104
2 1.58 ± 0.13 8.2 105
3 1.55 ± 0.06 3.8 103
60.0 1 57.3 ± 4.42 7.7 95.4
2 61.7 ± 5.70 9.2 103
3 62.8 ± 5.68 9.0 105
400 1 364 ± 20.3 5.5 91.1
2 393 ± 37.0 9.4 98.1
3 378 ± 16.2 4.3 94.4
Inter-day variation (18 replicate at each concentration)
0.48 0.54 ± 0.04 7.4 112
1.50 1.57 ± 0.07 4.5 105
60.0 60.6 ± 5.56 9.1 101
400 378 ± 27.2 7.1 94.5
Table 3 Stability and dilution integrity data of QUE in rat plasma.
Stability Nominal concentration
(ng/mL) (n= 6)
Mean ± SD (ng/mL) Precision (CV %) Accuracy (%)
Bench top (6 h) 1.50 1.60 ± 0.06 3.7 106
400 374 ± 15.0 4.0 93.5
Freeze thaw (3 cycle) 1.50 1.55 ± 0.10 6.5 104
400 372 ± 25.0 6.0 93.0
In injector (48 h) 1.50 1.63 ± 0.06 3.5 108
400 428 ± 11.37 2.7 107
60 days at 80 C 1.50 1.43 ± 0.13 8.8 95.0
400 365 ± 29.12 7.9 91.2
Dilution integrity 225 218.2 ± 12.9 5.9 97.0
450 433.0 ± 12.2 2.8 96.3
Table 2 Extraction recovery and matrix effect (three QC samples) in rat plasma (n= 6).
Compound Nominal concentration (ng/mL) Extraction recovery Matrix eﬀects
%Mean ± SD CV% %Mean ± SD CV%
Quetiapine 1.50 76.9 ± 5.8 7.6 89.8 ± 3.7 4.1
60.0 73.9 ± 8.0 10.8 87.2 ± 2.5 2.9
400 71.4 ± 4.9 6.9 86.7 ± 3.8 4.4
Mean 74.1 ± 2.7 3.7 87.9 ± 1.6 1.9
IS 20.0 67.3 ± 3.6 5.4 80.7 ± 3.2 4.0
UHPLC-MS/MS assay for quetiapine determination 7ether, diethyl ether, dichloromethane, ethyl acetate, chloroform
and n-hexane are commonly used as extracting solvents for
liquid–liquid extraction. But here considering environment,
health, and safety concerns (EHS); ethyl acetate, tertiary butyl
ethyl ether and 2-butanol were tried as extracting solvents.
Finally, ethyl acetate produced better result compared to others
andwas used as extracting agent in sample preparation. Liquid–
liquid extraction is also employed in sample preparation of pre-
vious green bio-analytical assay (Cheregi et al., 2013), but 1-oct-
anol was used as an extracting agent there followed by direct
injection of large volume of the organic layer for analysis.Please cite this article in press as: Iqbal, M. UHPLC-MS/MS assay using environment
in rat plasma. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabThe developed UHPLC-MS/MS method using environ-
ment friendly organic solvents allow a fast and reliable deter-
mination of QUE plasma concentrations using 200 ll of
plasma with a calibration range of 0.45–500 ng/mL and LLOQ
0.45 ng/mL. The method was successfully validated according
to the current effective ofﬁcial guidelines for bioanalytical
method validation and was successfully applied in a pharmaco-
kinetic interaction study of QUE in rats. Since this assay was
developed and validated in rat plasma samples, so it cannot
be directly used for application in clinical samples or therapeu-
tic drug monitoring. At least, partial validation in terms offriendly organic solvents: A green approach for fast determination of quetiapine
jc.2014.11.039
Figure 4 Mean ± SEM plasma concentration-time curves of
QUE after a single oral dose of 25 mg/kg with or without an oral
dose of GTE 175 mg/kg.
8 M. Iqbalprecision and accuracy is necessary before application in
human samples.
5. Conclusions
A green bioanalytical UHPLC-MS/MS method was developed
and validated for the rapid determination of QUE in rat
plasma using environment friendly and low toxic organic sol-
vents. The developed method was successfully applied in phar-
macokinetic study of QUE with GTE in rats. Replacement of
traditional organic modiﬁers such as methanol or acetonitrile
with ethanol did not produce any impact on peak symmetry
and elution of both analyte and IS. Capacity of withstanding
high back pressure (can handle the high viscosity characteristic
of ethanol) along with AQUITY BEH column, 50 · 2.1 mm,
i.d. 1.7 lm (leads to reduction of solvent required for separa-
tion and shortening of analysis time) enable UHPLC-MS/
MS, the suitable equipment for green bioanalytical assay.
Therefore, the present study shows the advantage of using less
harmful solvents which protect environment from hazardous
and polluting chemicals. Moreover, laboratory staffs are less
exposed to toxic and corrosive organic solvents.
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